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JACC Fcbma~, H.a)8 ABSTRAtT[S ~ l~, lcr 279A 
Methods: The distal superficial femoral arteries of rabl~is were hgated, the 
ligatures were removed at 24 or 48 hours, urekinaso ( 10,000 U/kg) was given 
intravenously, and th6 vessels win. harvostnd at 2 weeks. Control vessels 
were all,sooted but not I~ted  lnllmal and medial areas were quantified with 
computer im~go analysis of Verhoff-von Gelsen stainnd sechons. 
Re,~J/tS: Complete clot lydia with urekinase was documented histologically 
following 48 hour oocluston (n .  4) herve~led 24 houre aller lhrembolysis. 
Mean intirr~ to medi~l ref=os were 0,043 ± 0,00~ S~ (n = 5) for control, 0.072 
~: 0,0!2 (n = 5, p = 037 vs. control) for 24 hour and 0 J83 ~ 0<033 (n ~ 6, 
p =- 0,0004 ve, ~t ro | ,  p ~ 0.003 w, 24 hogr vessels) for 48 hour threm- 
bo~e~mperfused vee~els, Hislolog~c analysis with spa¢itl mono¢!onat anti- 
t:~dme demo~st~ted that the l'l~otnli!11~ 0! reperfused Veitsela were den! ly  
inlillrated with ~a¢;lln po~ve Cells. 
Con~/u~lot'l; P I  Ihiorld~osis (~14 hours), even after' succelstul 
fepeftgsio~, i l  il'itimal th~cker',lng, These results provide a novel merh. 
anism tot' the high incidence O! reStenosis attar reped~smn o( chromcally 
o~luded affenos. 
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11~'~5-11-] FI I l167~53, a C'ylokine Supp ie l~ ive  Agent ,  
Reduces  Myocard ia l  I=chemla-Reper lu=ion  In jury  
In Rats  
S. HoshKfa. N. Yamashita. J. Tar~ouchi, Y. Yamada. T. Kuzuya. M. Hen 
Osaka Uneven. Osaka Rosal Hosp~al. Japan 
Background: FR167653 is a specific irffubitor o! p38 E',AP kinasa acidity 
and inflicts the productmn of inflammatory c'ytokmes uch as tumor necros~s 
lactor-~ (TNF--~) and intedeukin-ttl (IL-ip) in human mo:K~/tes in a dose 
dependent manner (IC50. TNF-~: 1.1 i=M. IL-16:0.088 I=M). 
MeH~:~s: We exan~ned the effecl of FR16"/653 on the propagation of 
myocarckat intarctmn resulting from coronary occlusmn-reserfusion and the 
l~me course of express=on el these cytokmes in myocardial hssue in rats. My- 
ecardial infarction was induced by coronary hgation for 20 rnmutas followed 
by 24 hours of reperfus~on, Infarct size was evaluated by a dual stainng 
method using TTC an~ Evans blue dye. 
ResulTs: Although nemodyPamio parameters did not differ signifi~zr~y 
during occluslon-reperfusion, the size of the infarct was reduced by intra- 
venous admm~strabon of FR167653 before occlusion (contrel: 46 ± 2%; FR 
I lloJ~g: 19 ± 2%; 10 pg~g: 17 ± 2%, p < 0.05). mRNA of these cytokines 
assessed by RT-PCR was significantly increased during occfusmn and reper- 
fusion in ischemio myocardium (indicated as TNF--~ or IL-t p/G3DPH. TNF-~: 
before oco!usion 0.38 ~ 0.09, 20-minute oCClusiOn 0.77 :~ 0.13. 60-mince 
reperfusion 1.49 ± 0.16. p < 0.05 respectrvely; IL-I~: before occlusion 0.09 
± 0.02. 20-minute occlusion 0.31 ± 0.03, 60-minute reperfu~mn 0.34 :~ 0.04, 
p < 0.05 respectively). However, FR167653 significantly reduced the exprec,- 
sign of these Cytokines (TNF-o: 20-minute occlusion 0.49 ± 005, 60-minute 
repeffusion 0.72 ± 0.18; IL-lp: 20-minute occlusion 0.03 = 0.01.60-minute 
reped'usion 0.09 ± 0.03). 
Cc."~'lus~on: The expression of inflammatory cytokines increases in is- 
chem~Jrepedused myocardium and the inhibition of the augmented expres- 
sion of cytokines by FR167653 effectively reduces myocardial Lschemia- 
reperfusion injury. 
i 1115-12 i Effects of ORG 30029, Dobutamine, and High 
Perfusate Calcium on Function and Metabolism in 
Rat Hear t  
D.J. Grandis, G.A. MacGowan, A.P. Koretsky Pittsburgh NMR Center for 
Biomedical Research. Pittsburgh, PA. LISA 
Background: ORG 30029 (N-bydroxy-5 6-dimethoxy-benzo [b] thiophene-2- 
carboximidamide HCI) is a calcium sensitizing agent that increases Contrac- 
tility without significantly altenng calcium transient amplitude. The purpose 
of this study was to compare the effects of ORG 30029 on ca'diac function 
and metabolism to that of high perfusate calcium and dobutamine; which 
increase calcium transients. 
Methods: Isovolumic, Langendorft-pedused rat heads were paced (5 Hz) 
while oxygen consumption (MVO~, mcmol/min/gm), high energy phosphates 
by 3,p NMR, lactate production, and force-time integral (FTI, dynes.secs) 
were measured during control and agents. Effects on basal metabolism were 
determined in KCI-arrested heads. 
Results: Each agent increased contractility in a dose-dependent manner. 
Despite an increase of 50% in systolic pressure and a 17% in FTI from control 
ORG 30029 had no signdicant effect on MVO~ at the lower 00sea (n ; 12) 
HowevOr, ¢~utam;ne in ~ 7) and h~ Pe~te  ~lclum in ,= 7i rauseo a 
65% increase =n Sy~t01ic preslure and ~ 17% increa~ in F I I  and a ~/ ;  at~ 
41% in MVO~, respectively (p .  0 05) Contra¢tde economy (FTI,lvlVO~) was 
,ncreaSed by ORG 30029, decreased by dobutam~ne, end ur~tk~.~e~  
podus,~1e calcium compure¢l to centre! W < 0,05), High ~n~'~/~,  
laclafe product~,~, ~nd ba~.l I!~-~OhSm were rma!~rsO by the~e 
Conctu'3mn. The different en~tef~ @ire±t= o( ORG 30029, (to0u~m~me, 
and h~gh pectate  d~cium may be accounted for, in p~,  by ~ ~n 
energy for ¢.alcium handling, 
~ ~  o f  In t r=~nou= AmioOmne on  Ventdcu lar  
Vu l r~nlb l l l ty :  An  Opt l~ l  InMging l l tudy  In 
Rabbit  I, IR r ta  
S..F Lin, Y-W, Qian, R J  Sung. Vande~o/tt Unto, Nastlw/t~, TN; Stanford 
Un~., StantoKt, CA, USA 
Backgrouncf. Intravenous am~rena (Am) is being cons~ered to~ mcorp~ 
rattan into protocols for advanced cardiac life st¢~oit in the lmatment of vim. 
tncular hbflllatwon (VF) or hemoo~mra l ly  unstable ventncular tachycanJa 
(VT), We studied Am effects On ventncular vutnerab~Irly in six Langendo~- 
ped~ed rabbit hea~. 
Methods: High .-speed uptlcal imegnlg was ulilized, without uncoupling 
agents, to observe wavefrent dynamics dunng and after shock ($2) applra. 
f=on through mfemel leads ,n the pulmonary artery and left ventrtcular ape=. 
A monophas¢ 5 ms $2 o! vanous strengths was applied at ~ coupling 
intervals after 20 dnving stimuli. The ventficular vulnerable period (VVP) and 
rne upper limit ot vemncular vulnerebtltty (ULV) were determined before and 
after addition of Am at 1.5 rag/rot. The action polential ~Jretion (AP~)  was 
also measured at pacing cycle lengths ot 500 ms and 350 ms. 
ResuffS: Am ~d not induce Signff:cant e ~  in APDso duflng 500 ms 
paong (137.7 ± 4.7 ms ~ 142.8 ± 1.6 ms, p = NS). However, dunng 
pacing at 350 ms, Am significantly increased APDg0 (111.8 ± 62  ms 
134.0 ± 6.5 ms, p < 0.05). Am also s,hifted the mid-point of VVP to the 
right (160.0 ± 11.5 ms ~ 195.0 ± 25.2 ms, p < 0.05). Fuffhermore, Am 
signY~candy increased ULV (162.5 + 77.7 V ~ 212.5 ± 32.3 V, p < 0.05). 
After Am ffeatmerd, arrhylhmlc wavef~mts propagated more slowly and were 
organized into regular V'T (5/6 hearts). The dominant army~rma cycle leng~ 
increased significantly a~er drug treatment (96.5 ± 15.9 ms ~ 132.8 ± 172 
me. p < 0.05). 
Conclusion: Am.induced preferential prolongation of APD at shod cycle 
lenglh may be the pnmary mechanism responsible for its reductlon in VF 
inducibility and tim increased an'hythmlc wavefront stabil~'y Whether the 
assooated increase in ULV indicates an increase in the defibnllatmn threshold 
needs further study. 
~ Beneficial Effects During Ischemia-Repedusion: 
Synergistic Action of Levosimendan and 
Dobutamine  
F. Sam, JD. Ruidera. S. Ngny. TM Suter, WS COluccL C.S. Apstein, 
FR  EbedL Boston Unfree,  MA. USA 
Lcvosimendan (Levo), a novel Cal'-sensitizing agent, has not been used in 
acJte ischemio syndromes. We hypothesized that Ca 2° -sansmzers, llke Levo, 
mey overcome acute ischem~c pump failure, therefore we tested whether 
Levo alone Or with dobutamme (Debt could improve ischemic contractile fail. 
ure w~thout increasing diastolic dysfunction during ischemta and repeduston 
(lath + Rep). Isolated, blood perfused, movolumio rabbit hearts were sub- 
iected to 40' tsch by reducing coronary flow to -- 25% of baseline, followed 
by 35 Rep. Four groups (n = 6--8/group) were studied: saline (St, Levo (0.4 
l=M), Oob (5 ~M) and Levo + Dob. Surpnsingly, Levo alone had no effe¢l on 
systolic or diastolic function, but caused coronary vasodilatatton dunng Isch 
(coronary perfusion pressure at 40' Isch: 18 ± 1 vs. 21 ± 1 mmHg; Levo vs. 
S; p .: 0.05) and at 15' Rep (42 ± 2 vs. 86 ± 9 r~mHg; Levo vs. S. p < ¢L001 ). 
Dob atone worsened d~.;.~tolic dysfunction wh,~'3~ was improved by L-~/o + 
Dob (LVEDP at 35 Rep: 25 ± 5 vs. 14 ± 3 mmHg, DOb vs. Le:,o + Dob: 
p ~ 0.001). Levo + Dob and Dob exerted a pos:tnm inotro~c effect dunng 
ischemia (LV developed pressure (LV OevP) at 4,Y lsch: 72 ± 4 and 68 ± 2 
vs. 51 ± 4 mm Hg; p < 0.001 vs, St. Dunng lsch, MVO2 was unaffected by 
Levo but inomased with Dob (12%) and Love + Dob (17%) (p < 0,001 vs. 
St. % recovery of LV DovP at 15' Rep was furthe= increased in Levo + Dob 
compared to Dob alone (106 ± 7 vs. 89 ± 3</0; p < 0.001 ). 
Conclusion: During Isch + Rep. levosimendan in combination with dobu- 
famine had a positive inotropic effect that surpassed that of dobutamine alone 
and ameliorated post-ischemic diastolic dysfunction. This combination may 
be clinically useful in acute ischemic syndromes. 
